{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:51:32Z","timestamp":1791579092519,"version":"4.3.4"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI 21\/01310"],"award-info":[{"award-number":["PI 21\/01310"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI 24\/01769"],"award-info":[{"award-number":["PI 24\/01769"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.aohep.2026.102466","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:30:58Z","timestamp":1791473458000},"page":"102466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Portopulmonary hypertension: an integrated approach to diagnosis, risk stratification, and management"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6039-0272","authenticated-orcid":false,"given":"Jes\u00fas","family":"Donate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"del Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4705-7744","authenticated-orcid":false,"given":"Andr\u00e9s","family":"Tenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Jes\u00fas del Cerro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Albillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9254-3891","authenticated-orcid":false,"given":"Luis","family":"T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.aohep.2026.102466_bib0001","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International Liver Transplant Society Practice Guidelines","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0002","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","article-title":"Clinical risk factors for portopulmonary hypertension\u2020","volume":"48","author":"Kawut","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.aohep.2026.102466_bib0003","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.21431","article-title":"Portopulmonary hypertension: Results from a 10-year screening algorithm","volume":"44","author":"Krowka","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.aohep.2026.102466_bib0004","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/jhep.2003.50060","article-title":"Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study","volume":"37","author":"Colle","year":"2003","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2026.102466_bib0005","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.mayocp.2024.08.011","article-title":"Echocardiography Screening of Consecutive Patients With Portal Hypertension Referred to Mayo Clinic for Liver Transplant Evaluation","volume":"100","author":"Burger","year":"2025","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"10.1016\/j.aohep.2026.102466_bib0006","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/hepr.13560","article-title":"Prevalence and characteristics of portopulmonary hypertension in cirrhotic patients who underwent both hepatic vein and pulmonary artery catheterization","volume":"50","author":"Atsukawa","year":"2020","journal-title":"Hepatology Research"},{"issue":"2","key":"10.1016\/j.aohep.2026.102466_bib0007","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary Arterial Hypertension","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.aohep.2026.102466_bib0008","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary Arterial Hypertension in France","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.aohep.2026.102466_bib0009","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups","volume":"8","author":"Swanson","year":"2008","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1016\/j.aohep.2026.102466_bib0010","first-page":"906","volume":"141","author":"Krowka","year":"2012","journal-title":"Portopulmonary Hypertension. Chest."},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0011","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01904-2018","article-title":"Diagnosis of pulmonary hypertension","volume":"53","author":"Frost","year":"2019","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0012","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2020.02.021","article-title":"Portopulmonary hypertension in the current era of pulmonary hypertension management","volume":"73","author":"Savale","year":"2020","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2026.102466_bib0013","doi-asserted-by":"crossref","first-page":"E1586","DOI":"10.1097\/TXD.0000000000001586","article-title":"The Clinical Course of Portopulmonary Hypertension and Outcomes With Endothelin Receptor Antagonist Treatment: Observational Study of Data From the US Organ Procurement and Transplantation Network","volume":"10","author":"Dubrock","year":"2024","journal-title":"Transplant Direct"},{"issue":"3","key":"10.1016\/j.aohep.2026.102466_bib0014","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cld.2024.03.005","article-title":"Pulmonary Complications of Portal Hypertension","volume":"28","author":"Bommena","year":"2024","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.aohep.2026.102466_bib0015","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur Respir J"},{"issue":"38","key":"10.1016\/j.aohep.2026.102466_bib0016","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.aohep.2026.102466_bib0017","article-title":"International Liver Transplantation Society practice guideline update on portopulmonary hypertension","author":"DuBrock","year":"2025","journal-title":"Liver Transplantation."},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0018","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01654-2019","article-title":"Pulmonary arterial hypertension with below threshold pulmonary vascular resistance","volume":"56","author":"Ratwatte","year":"2020","journal-title":"European Respiratory Journal"},{"issue":"13","key":"10.1016\/j.aohep.2026.102466_bib0019","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/CIRCULATIONAHA.115.020207","article-title":"Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.aohep.2026.102466_bib0020","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/hep.31164","article-title":"Vasomodulators and Liver Transplantation for Portopulmonary Hypertension: Evidence From a Systematic Review and Meta-Analysis","volume":"72","author":"Deroo","year":"2020","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.aohep.2026.102466_bib0021","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/lt.26422","article-title":"Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception","volume":"28","author":"DuBrock","year":"2022","journal-title":"Liver Transplantation."},{"key":"10.1016\/j.aohep.2026.102466_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2022.107022","article-title":"Porto-pulmonary arterial hypertension: Translation of pathophysiological concepts to the bedside","volume":"145","author":"Mazzola","year":"2022","journal-title":"Vascul Pharmacol"},{"issue":"8","key":"10.1016\/j.aohep.2026.102466_bib0023","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/0003319710369101","article-title":"Plasma Cytokines and Portopulmonary Hypertension in Patients With Cirrhosis Waiting for Orthotopic Liver Transplantation","volume":"61","author":"Pellicelli","year":"2010","journal-title":"Angiology"},{"issue":"4","key":"10.1016\/j.aohep.2026.102466_bib0024","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1086\/688489","article-title":"Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension","volume":"6","author":"Dubrock","year":"2016","journal-title":"Pulm Circ"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.amjmed.2004.11.007","article-title":"Thromboxane-dependent portopulmonary hypertension","volume":"118","author":"Maruyama","year":"2005","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.aohep.2026.102466_bib0026","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/liv.12791","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: Recent knowledge in pathogenesis and overview of clinical assessment","volume":"35","author":"Raevens","year":"2015","journal-title":"Liver International"},{"issue":"5","key":"10.1016\/j.aohep.2026.102466_bib0027","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1053\/j.gastro.2011.06.053","article-title":"Prevalence of Spontaneous Portosystemic Shunts in Patients With Portopulmonary Hypertension and Effect on Treatment","volume":"141","author":"Talwalkar","year":"2011","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.aohep.2026.102466_bib0028","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jacc.2004.02.033","article-title":"Pathologic assessment of vasculopathies in pulmonary hypertension","volume":"43","author":"Pietra","year":"2004","journal-title":"J Am Coll Cardiol [Internet]"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0029","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0272-5231(05)70296-3","article-title":"PULMONARY HYPERTENSION IN CHRONIC LIVER DISEASE","volume":"17","author":"Mandell","year":"1996","journal-title":"Clin Chest Med [Internet]"},{"issue":"25","key":"10.1016\/j.aohep.2026.102466_bib0030","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMra2000348","article-title":"Pulmonary Arterial Hypertension","volume":"385","author":"Hassoun","year":"2021","journal-title":"New England Journal of Medicine [Internet]"},{"issue":"4","key":"10.1016\/j.aohep.2026.102466_bib0031","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1665-2681(19)31832-0","article-title":"Portopulmonary hypertension: state of the art","volume":"7","author":"Porres-Aguilar","year":"2008","journal-title":"Ann Hepatol"},{"issue":"05","key":"10.1016\/j.aohep.2026.102466_bib0032","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0037-1606251","volume":"38","author":"Savale","year":"2017","journal-title":"Portopulmonary Hypertension. Semin Respir Crit Care Med."},{"issue":"9","key":"10.1016\/j.aohep.2026.102466_bib0033","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1164\/rccm.200809-1472OC","article-title":"Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease","volume":"179","author":"Roberts","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.aohep.2026.102466_bib0034","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.31314","article-title":"Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2)","volume":"73","author":"Al-Naamani","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0035","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s42003-023-05193-3","article-title":"Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertension","volume":"6","author":"Jose","year":"2023","journal-title":"Commun Biol"},{"issue":"7","key":"10.1016\/j.aohep.2026.102466_bib0036","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/rccm.201807-1236OC","article-title":"Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension","volume":"199","author":"Nikolic","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.aohep.2026.102466_bib0037","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII \u2013 Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0038","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cld.2022.08.002","article-title":"Portopulmonary Hypertension","volume":"27","author":"Lai","year":"2023","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.aohep.2026.102466_bib0039","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0016-5085(91)90225-A","article-title":"Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic hemodynamics","volume":"100","author":"Hadengue","year":"1991","journal-title":"Gastroenterology"},{"issue":"126","key":"10.1016\/j.aohep.2026.102466_bib0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1183\/09059180.00005112","article-title":"Early detection and management of pulmonary arterial hypertension","volume":"21","author":"Humbert","year":"2012","journal-title":"European Respiratory Review"},{"issue":"4","key":"10.1016\/j.aohep.2026.102466_bib0041","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1378\/chest.112.4.980","article-title":"Distinctive Clinical Features of Portopulmonary Hypertension","volume":"112","author":"Kuo","year":"1997","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0042","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jhep.2025.01.029","article-title":"EASL Clinical Practice Guidelines on TIPS","volume":"83","author":"Bureau","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102466_bib0043","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9243","article-title":"Role of echocardiography in screening for portopulmonary hypertension in liver transplant candidates: a meta-analysis","volume":"8","author":"Yin","year":"2020","journal-title":"PeerJ"},{"issue":"6","key":"10.1016\/j.aohep.2026.102466_bib0044","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/lt.23649","article-title":"Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: An analysis of cutoff values","volume":"19","author":"Raevens","year":"2013","journal-title":"Liver Transplantation"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jcmg.2012.11.002","article-title":"Echocardiography in liver transplant candidates","volume":"6","author":"Garg","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.aohep.2026.102466_bib0046","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4250\/jcvi.2018.26.e2","article-title":"Correlation between Echocardiographic Pulmonary Artery Pressure Estimates and Right Heart Catheterization Measurement in Liver Transplant Candidates","volume":"26","author":"Habash","year":"2018","journal-title":"J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.aohep.2026.102466_bib0047","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001757","article-title":"The Utility of Follow-up Transthoracic Echocardiogram to Screen for Severe Portopulmonary Hypertension (POPH) in Patients Granted POPH Model for End-stage Liver Disease (MELD) Exceptions","volume":"11","author":"del Valle","year":"2025","journal-title":"Transplant Direct"},{"issue":"6","key":"10.1016\/j.aohep.2026.102466_bib0048","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.rce.2015.02.019","article-title":"Hipertensi\u00f3n pulmonar y cirrosis hep\u00e1tica","volume":"215","author":"T\u00e9llez Villajos","year":"2015","journal-title":"Rev Clin Esp"},{"issue":"3","key":"10.1016\/j.aohep.2026.102466_bib0049","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrgastro.2013.210","article-title":"Cirrhotic cardiomyopathy: Pathogenesis and clinical relevance","volume":"11","author":"Wiese","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102466_bib0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/liv.12562","article-title":"Characteristic haemodynamic changes of cirrhosis may influence the diagnosis of portopulmonary hypertension","volume":"35","author":"Chiva","year":"2015","journal-title":"Liver International"},{"issue":"5","key":"10.1016\/j.aohep.2026.102466_bib0051","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/hep.510230507","article-title":"Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: Effects on right ventricular function","volume":"23","author":"Van der Linden","year":"1996","journal-title":"Hepatology [Internet]"},{"issue":"5","key":"10.1016\/j.aohep.2026.102466_bib0052","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MEG.0b013e32835d09fe","article-title":"Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis","volume":"25","author":"Busk","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2026.102466_bib0053","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/gut.39.4.600","article-title":"Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients","volume":"39","author":"Colombato","year":"1996","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0054","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.chest.2018.01.009","article-title":"Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension","volume":"154","author":"Frantz","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.aohep.2026.102466_bib0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.hrtlng.2024.08.018","article-title":"Serum uric acid and pulmonary arterial hypertension: A two-sample Mendelian randomization study","volume":"68","author":"Tan","year":"2024","journal-title":"Heart & Lung"},{"issue":"2","key":"10.1016\/j.aohep.2026.102466_bib0056","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00332-2020","article-title":"Serum and pulmonary uric acid in pulmonary arterial hypertension","volume":"58","author":"Savale","year":"2021","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0057","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.chest.2023.10.038","article-title":"Advancing Risk Stratification in Pulmonary Arterial Hypertension Through Cardiac MRI","volume":"165","author":"Frantz","year":"2024","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.aohep.2026.102466_bib0058","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.3390\/ijms24098050","article-title":"Identification of Potential Biomarkers for Group I Pulmonary Hypertension Based on Machine Learning and Bioinformatics Analysis","volume":"24","author":"Hu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.aohep.2026.102466_bib0059","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/imj.14751","article-title":"Portopulmonary hypertension: prognosis and management in the current treatment era \u2013 results from the REHAP registry","volume":"51","author":"Lazaro Salvador","year":"2021","journal-title":"Intern Med J"},{"issue":"7","key":"10.1016\/j.aohep.2026.102466_bib0060","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/TP.0000000000001666","article-title":"Predictors of Waitlist Mortality in Portopulmonary Hypertension","volume":"101","author":"DuBrock","year":"2017","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.aohep.2026.102466_bib0061","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/lt.26091","article-title":"Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension","volume":"27","author":"Jose","year":"2021","journal-title":"Liver Transplantation"},{"key":"10.1016\/j.aohep.2026.102466_bib0062","article-title":"Early portopulmonary hypertension predicts mortality in patients with cirrhosis: insights from the PORTO-DETECT cohort","author":"T\u00e9llez","year":"2025","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102466_bib0063","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00107-2022","article-title":"Outcomes of cirrhotic patients with pre-capillary pulmonary hypertension and pulmonary vascular resistance between 2 and 3 Wood Units","volume":"60","author":"Certain","year":"2022","journal-title":"European Respiratory Journal"},{"issue":"8","key":"10.1016\/j.aohep.2026.102466_bib0064","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033847","article-title":"Association of Cardiopulmonary Hemodynamics and Mortality in Veterans With Liver Cirrhosis: A Retrospective Cohort Study","volume":"13","author":"Jose","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.aohep.2026.102466_bib0065","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MEG.0000000000002322","article-title":"Predictors of survival in portopulmonary hypertension: a 20-year experience","volume":"34","author":"Aggarwal","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0066","doi-asserted-by":"crossref","first-page":"51","DOI":"10.15403\/jgld-1279","article-title":"Relationship between NT-proBNP and cardio-renal dysfunction in patients with advanced liver cirrhosis","volume":"23","author":"Cavasi","year":"2014","journal-title":"J Gastrointestin Liver Dis"},{"issue":"10","key":"10.1016\/j.aohep.2026.102466_bib0067","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/gut.52.10.1511","article-title":"Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease","volume":"52","author":"Henriksen","year":"2003","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.aohep.2026.102466_bib0068","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01325-2024","article-title":"Treatment algorithm for pulmonary arterial hypertension","volume":"64","author":"Chin","year":"2024","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0069","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-019-1981-0","article-title":"Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: A randomized, controlled, double-blind, parallel group study (EDITA study)","volume":"21","author":"Pan","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-024-03363-0","article-title":"Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study","volume":"26","author":"Xanthouli","year":"2024","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.aohep.2026.102466_bib0071","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2213-2600(19)30091-8","article-title":"Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial","volume":"7","author":"Sitbon","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0072","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s41030-023-00251-x","article-title":"Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS\/OrPHeUS Studies","volume":"10","author":"Kim","year":"2024","journal-title":"Pulm Ther"},{"issue":"5","key":"10.1016\/j.aohep.2026.102466_bib0073","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.healun.2019.12.008","article-title":"Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial","volume":"39","author":"Preston","year":"2020","journal-title":"The Journal of Heart and Lung Transplantation"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0074","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1183\/09031936.00117511","article-title":"Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension","volume":"41","author":"Savale","year":"2013","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0075","first-page":"42","article-title":"Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension","volume":"22","author":"Fisher","year":"2015","journal-title":"Can Respir J"},{"key":"10.1016\/j.aohep.2026.102466_bib0076","doi-asserted-by":"crossref","first-page":"PA3050","DOI":"10.1183\/13993003.congress-2018.PA3050","article-title":"Efficacy and safety of tadalafil in portopulmonary hypertension","author":"Jevnikar","year":"2018","journal-title":"Pulmonary hypertension. European Respiratory Society"},{"issue":"2","key":"10.1016\/j.aohep.2026.102466_bib0077","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045894018769305","article-title":"Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1\/-2 studies","volume":"8","author":"Cartin-Ceba","year":"2018","journal-title":"Pulm Circ"},{"issue":"39","key":"10.1016\/j.aohep.2026.102466_bib0078","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.3748\/wjg.v16.i39.5009","article-title":"Haemodynamic and renal effects of tadalafil in patients with cirrhosis","volume":"16","author":"Kalambokis","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102466_bib0079","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious Effects of \u03b2-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension","volume":"130","author":"Provencher","year":"2006","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.aohep.2026.102466_bib0080","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cgh.2021.07.018","article-title":"North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension","volume":"20","author":"Boike","year":"2022","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"6","key":"10.1016\/j.aohep.2026.102466_bib0081","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2024.07.032","article-title":"EASL Clinical Practice Guidelines on liver transplantation","volume":"81","author":"Samuel","year":"2024","journal-title":"J Hepatol"},{"issue":"Supplement 3","key":"10.1016\/j.aohep.2026.102466_bib0082","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1002\/lt.20975","article-title":"Model for end-stage liver disease (MELD) exception for portopulmonary hypertension","volume":"12","author":"Krowka","year":"2006","journal-title":"Liver Transplantation"},{"issue":"4","key":"10.1016\/j.aohep.2026.102466_bib0083","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/jlts.2000.6356","article-title":"Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation","volume":"6","author":"Krowka","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.aohep.2026.102466_bib0084","doi-asserted-by":"crossref","unstructured":"DuBrock HM, Runo JR, Sadd CJ, Burger CD, Cartin-Ceba R, Rosen CB, et al. Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure \u226535 mm\u2009Hg. Transplant Direct. 2020 Nov 10;6(12):e630.","DOI":"10.1097\/TXD.0000000000001085"},{"issue":"7","key":"10.1016\/j.aohep.2026.102466_bib0085","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/lt.25747","article-title":"Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis","volume":"26","author":"Krowka","year":"2020","journal-title":"Liver Transplantation"},{"issue":"10","key":"10.1016\/j.aohep.2026.102466_bib0086","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1097\/TP.0000000000003490","article-title":"Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension","volume":"105","author":"Cartin-Ceba","year":"2021","journal-title":"Transplantation."},{"issue":"2","key":"10.1016\/j.aohep.2026.102466_bib0087","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/TP.0000000000003248","article-title":"Long-term outcomes and survival in moderate-severe portopulmonary hypertension after liver transplant","volume":"105","author":"Sadd","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.aohep.2026.102466_bib0088","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0168-8278(23)00555-X","article-title":"The new diagnostic criteria of portopulmonary hypertension identify a group of patients with cirrhosis at high risk of death","author":"T\u00e9llez","year":"2023","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2026.102466_bib0089","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01323-2024","article-title":"Risk stratification and treatment goals in pulmonary arterial hypertension","volume":"64","author":"Dardi","year":"2024","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.aohep.2026.102466_bib0090","article-title":"Unmet needs in diagnosis and management of portopulmonary hypertension: How far have we reached?","author":"Krowka","year":"2024","journal-title":"Hepatology"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126002863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126002863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:25:53Z","timestamp":1791577553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268126002863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":90,"alternative-id":["S1665268126002863"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102466","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Portopulmonary hypertension: an integrated approach to diagnosis, risk stratification, and management","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102466"}}